Spaans et al., investigated somatic mutations in gynecological cancers and found that PIK3A, PTEN and KRAS were the most frequently occurring mutations, with rates being 22, 18 and 12%, respectively [50]. This evidence concerns the gene KRAS and female reproductive organ cancer.